Incyte Corp (INCY)

NASDAQ

$115.65

Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware.

Sector:

Industry:

68 analysts

Buy

Target: $113.82 (-1.58%)

Market Cap

$23B

PEG Ratio

0.00

EPS 5Y CAGR

+27.16%

Profit Margin

23.8%

Adjust inflation

Log

Valuation

Market Cap$23B

P/E15.82

Forward P/E15.06

PEG0.00

P/S4.28

P/B4.06

Profitability

Total Revenue (TTM)$5.36B

Gross Profit (TTM)$2.83B

EBITDA$1.71B

Profit Margin23.8%

Operating Margin23.7%

EPS$7.27

Financial Health

Free Cash Flow Yield6.59%

Growth & Risk

EPS 5Y CAGR+27.16%

Revenue 5Y CAGR+14.68%

FCF 5Y CAGR+14.67%

Beta (5Y)0.57

Sharpe Ratio1.60